EMA

Share

EMA

 •  October 16

Plan aims to ensure continuity of Agency’s operationsThe European Medicines Agency (EMA) has published today its Brexit Preparedness Business Continuity Plan. The plan, which was endorsed by the Management Board at its June 2017 meeting, aims to safeguard continuity of EMA’s operations to protect public health while the Agency prepares for its...

EMA

 •  October 13

SummaryThis is the first European Medicines Agency teleconference with the veterinary industry stakeholder associations, namely with AnimalhealthEurope (formerly IFAH Europe), European Group for Generic Veterinary Products (EGGVP) and the Association of Veterinary Consultants (AVC), on the United Kingdom's withdrawal from the European Union...

EMA

 •  October 13

SummaryThe three-day pharmacovigilance inspectors training course is for inspectors and assessors of both, veterinary and human units of EU/EEA Member States, and delegates from non-EU countries. The training will consist of presentations as well as breakout sessions during which participants will be given case studies and examples to discuss and...

EMA

 •  October 6

Board hears update on preparations for Brexit and adopts Agency’s mid-year reportBrexit preparationsAt its 5 October 2017 meeting in London, the Management Board of the European Medicines Agency (EMA) was updated on the Agency’s ongoing preparations for the withdrawal of the United Kingdom (UK) from the European Union (EU).The European Commission’s...

EMA

 •  October 4

Final preparations for change-over to new system underway for go live date on 22 November 2017On 22 November 2017, the European Medicines Agency (EMA) will launch a new and improved version of EudraVigilance, the European information system of suspected adverse reactions to medicines that are authorised or being studied in clinical trials in the...

EMA

 •  October 3

Accessibility for delegates and experts and staff retention are key to ensure Agency’s ability to functionThe European Medicines Agency (EMA) is today publishing the information it submitted to the European Commission in support of its assessment of the 19 Member States’ bids to host the Agency. This decision comes following the recent publication...

EMA

 •  October 3

Complaint dismissed in its entiretyThe General Court has ruled that there was no irregularity with the recruitment procedure and Professor Guido Rasi’s subsequent appointment as Executive Director of the European Medicines Agency (EMA) in 2011.The case was brought by a candidate in January 2012 appealing against the decision by the European...

EMA

 •  September 26

Staff survey indicates that the future of public health in Europe is at stakeTo complement the European Commission’s assessment of all bids for the relocation of the Agency submitted by Member States that will be published later this month, EMA is making available the results of its most recent staff retention survey, which raised serious concerns....

EMA

 •  September 12

Awareness session for international regulators and NGOs on the work of EMA and European medicines regulatory systemThe European Medicines Agency (EMA) will host an awareness session to present the European Union’s (EU) medicines regulatory system and EMA’s role in it to international regulators and non-governmental organisations.A clear...

EMA

 •  September 12

EMA to host a meeting with key stakeholders on the work of international health authorities and how to optimise collaborationThe European Medicines Agency (EMA) is organising a joint meeting with the European Centre for Disease Prevention and Control (ECDC) to discuss antimicrobial resistance.The event will take place at EMA’s premises in London on...